title: Manganese dosimetry: species differences and implications for neurotoxicity.
abstract: Manganese (Mn) is an essential mineral that is found at low levels in food, water, and the air. Under certain high-dose exposure conditions, elevations in tissue manganese levels can occur. Excessive manganese accumulation can result in adverse neurological, reproductive, and respiratory effects in both laboratory animals and humans. In humans, manganese-induced neurotoxicity (manganism) is the overriding concern since affected individuals develop a motor dysfunction syndrome that is recognized as a form of parkinsonism. This review primarily focuses on the essentiality and toxicity of manganese and considers contemporary studies evaluating manganese dosimetry and its transport across the blood-brain barrier, and its distribution within the central nervous system (CNS). These studies have dramatically improved our understanding of the health risks posed by manganese by determining exposure conditions that lead to increased concentrations of this metal within the CNS and other target organs. Most individuals are exposed to manganese by the oral and inhalation routes of exposure; however, parenteral injection and other routes of exposure are important. Interactions between manganese and iron and other divalent elements occur and impact the toxicokinetics of manganese, especially following oral exposure. The oxidation state and solubility of manganese also influence the absorption, distribution, metabolism, and elimination of manganese. Manganese disposition is influenced by the route of exposure. Rodent inhalation studies have shown that manganese deposited within the nose can undergo direct transport to the brain along the olfactory nerve. Species differences in manganese toxicokinetics and response are recognized with nonhuman primates replicating CNS effects observed in humans while rodents do not. Potentially susceptible populations, such as fetuses, neonates, individuals with compromised hepatic function, individuals with suboptimal manganese or iron intake, and those with other medical states (e.g., pre-parkinsonian state, aging), may have altered manganese metabolism and could be at greater risk for manganese toxicity.
authors.affiliation: Vanderbilt University, Nashville, Tennessee, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Aschner
authors.forename: Keith M
authors.initials: KM
authors.lastname: Erikson
authors.forename: David C
authors.initials: DC
authors.lastname: Dorman
mesh_terms: D000042:Absorption; D000328:Adult; D001812:Blood-Brain Barrier; D002490:Central Nervous System / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D019570:Inhalation Exposure; D008297:Male; D008345:Manganese / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics*; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011634:Public Health; D018570:Risk Assessment
chemical_list: D008345:Manganese